StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Incyte (INCY) PT Raised to $140 at Jefferies on 4Q Report, Jakafi Metrics
February 15, 2017 8:10 AM
Jefferies analyst Brian Abrahams reiterates Buy rating and raises price target on Incyte Corp. (NASDAQ: INCY) to $140 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Jefferies Reiterates Buy Rating and $140 PT on Incyte Corp. (INCY); EU Bari Label In-Line
February 17, 2017 8:37 AM
Incyte (INCY) PT Raised to $138 at RBC Capital Citing Growth in Jakafi
February 15, 2017 7:36 AM
Incyte (INCY): Raising PT On Additional Sources of Upside - BMO
February 15, 2017 6:15 AM
RBC Capital Reiterates Outperform Rating on Incyte (INCY) Following 4Q Results
February 14, 2017 9:37 AM
Incyte (INCY) Misses Q4 EPS by 8c
February 14, 2017 7:11 AM
Incyte (INCY), Agenus (AGEN) Announce Amendment to Collaboration Agreement
February 14, 2017 7:07 AM
Incyte Reports 2016 Fourth-Quarter and Year-End Financial Results, Provides 2017 Financial Guidance and Updates on Key Clinical Programs
February 14, 2017 7:00 AM
Incyte and Agenus Amend Collaboration Agreement
February 14, 2017 7:00 AM
